Abstract
Brain natriuretic peptide (BNP), is a 32 amino acid containing cardiac hormone released from the ventricles due to increased filling pressure and left ventricle wall stretch. For over a decade since its discovery, information is mounting to suggest its superiority over the other natriureic peptide, ANP, as a reliable measure of left ventricular systolic dysfunction. Measurement of BNP concentration in blood emerges as a sensitive and specific test for the identification of patients with congestive heart failure in the urgent-care setting. It is a potent, cost-effective addition to the diagnostic armamentarium and helps in the titration of following therapy and prognosis evaluation.
Original language | English |
---|---|
Pages (from-to) | 25-31+78 |
Journal | Harefuah |
Volume | 142 |
Issue number | 1 |
State | Published - Jan 2003 |
Keywords
- Atrial natriuretic peptide
- Brain natriuretic peptide
- Congestive heart failure
- Dyspnea
- Left ventricle ejection fraction